SGRY logo

Surgery Partners Inc. (SGRY)

$26.85

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on SGRY

Market cap

$3.51B

EPS

-0.67

P/E ratio

--

Price to sales

0.54

Dividend yield

--

Beta

1.859676

Price on SGRY

Previous close

$26.79

Today's open

$26.68

Day's range

$26.68 - $26.89

52 week range

$11.41 - $27.23

Profile about SGRY

CEO

J. Eric Evans

Employees

16000

Headquarters

Brentwood, TN

Exchange

Nasdaq Global Select

Shares outstanding

130881223

Issue type

Common Stock

SGRY industries and sectors

Healthcare

Healthcare Providers & Services

News on SGRY

SGRY Merger Investigation: Surgery Partners Investigated Over $23.50 per Share Take-Private Merger – Contact BFA Law if You Hold Shares

BFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest stockholder, Bain Capital, is rolling over its equity into the post-merger entity; current stockholders are notified to contact the firm. NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware.

news source

GlobeNewsWire • 13 hours ago

news preview

Surgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032

BRENTWOOD, Tenn., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has amended its previously announced solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos. 86881W AF9 / U86786 AD9 / U86786 AE7; ISINs US86881WAF95 / USU86786AD98 / USU86786AE71) (the “Notes”) to certain proposed amendments (the “Proposed Amendments”) to the indenture governing the Notes, dated as of April 10, 2024 (as supplemented, the “Indenture”), among the Issuer, the guarantors party thereto and Wilmington Trust, National Association, as trustee (the “Trustee”), to increase the consent fee payable to Holders who validly deliver (and do not validly revoke) consents prior to the Expiration Time (as defined below) from $2.50 to $5.00 per $1,000 in principal amount of Notes (the “Increased Consent Fee”).

news source

GlobeNewsWire • 13 hours ago

news preview

SHAREHOLDER NOTICE: Kaskela Law Firm Investigates Fairness of Proposed $25.00 Per Share Buyout Offer – Fair Price or Inadequately Low for Surgery Partners Inc. (SGRY) Shares?

PHILADELPHIA, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Kaskela Law announces that it is investigating the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine if the proposed buyout price is inadequately low and unfair to the company's investors. Click here to request additional information about this investigation: https://kaskelalaw.com/case/surgery-partners/ On November 9, 2026, Surgery Partners announced that it had entered into an amended agreement to be acquired by HealthSpan Partners at a price of $25.00 per share in cash.

news source

GlobeNewsWire • Nov 17, 2026

news preview

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Surgery Partners, Inc. (SGRY)

NEW YORK, Nov. 16, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Surgery Partners, Inc. ("SGRY" or the "Company") (NASDAQ: SGRY) stock prior to October 23, 2026 . You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of SGRY by HealthSpan Partners.

news source

PRNewsWire • Nov 17, 2026

news preview

SURGERY PARTNERS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Surgery Partners, Inc.'s Directors for Breach of Fiduciary Duties – SGRY

Scott+Scott Attorneys at Law LLP is investigating whether the directors of Surgery Partners breached their fiduciary duties to the Company's shareholders.

news source

GlobeNewsWire • Nov 16, 2026

news preview

Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032

BRENTWOOD, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), has commenced a solicitation of consents (the “Consent Solicitation”) from holders (“Holders”) of its outstanding $1,225,000,000 aggregate principal amount of 7.250% Senior Notes due 2032 (CUSIP Nos.

news source

GlobeNewsWire • Nov 16, 2026

news preview

Top 3 Health Care Stocks That May Collapse This Month

As of Nov. 16, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

news source

Benzinga • Nov 16, 2026

news preview

SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger

NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: SGRY) is being taken private by Bon Secours Mercy Health, Inc. Surgery Partners is incorporated in Delaware. If you are a current stockholder of Surgery Partners, Inc., you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/surgery-partners-merger-investigation.

news source

GlobeNewsWire • Nov 11, 2026

news preview

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine whether the proposed buyout price undervalues the company's shares.Click here for additional information: https://kaskelalaw.com/case/surgery-partners/On October 26, 2026, Surgery Partners announced that it had agreed to be acquired by HealthSpan Partners at a price of $23.50 per share in cash. Follo.

news source

Business Wire • Nov 10, 2026

news preview

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), ARRAY Technologies, Inc. (NASDAQ – ARRY), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC)

BALA CYNWYD, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

news source

GlobeNewsWire • Nov 10, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Surgery Partners Inc.

Open an M1 investment account to buy and sell Surgery Partners Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in SGRY on M1